Skip to nav Skip to content

Moffitt’s multispecialty Blood and Marrow Transplant and Cellular Immunotherapy team

If your medical team has suggested that you consider a bone marrow transplant, a specialist in the Blood and Marrow Transplant and Cellular Immunotherapy Program at Moffitt Cancer Center can help you decide whether this complex treatment is the right next step for you. As a National Marrow Donor Program (NMDP) transplant and collection center, Moffitt performs transplants to treat cancers that affect blood-forming tissues, such as leukemia and lymphoma, as well as to restore stem cells that were damaged or destroyed by high-dose chemotherapy or radiation treatment.

At Moffitt, we believe that cancer treatment must be highly individualized to reach its full potential. Therefore, we will provide you with opportunities to work one-on-one with a blood and bone marrow transplant specialist. In addition, you will also benefit from multiple expert opinions throughout your treatment journey. That’s because we emphasize teamwork, knowing that our accomplishments as a group can far exceed those of any single team member working alone. Through our unique multispecialty approach, we are able to truly optimize each patient's journey to ensure the best possible outcomes and quality of life.

Each specialist on Moffitt’s multispecialty Blood and Marrow Transplant and Cellular Immunotherapy team focuses exclusively on blood and bone marrow transplants. These experienced medical professionals include:

  • Physicians
  •  Advanced practice providers
  •  Nurses
  •  Transplant coordinators
  •  Pharmacists
  •  Clinical trial coordinators
  •  Social workers
  •  Apheresis specialists

Throughout the transplant process, a BMT transplant specialist will see you on a daily basis to perform examinations, evaluate your progress, keep you informed and answer any questions you may have. Remember, you will be one of the most important members of your treatment team, and we will encourage you to maintain an active role throughout your transplant and recovery process.

Medically reviewed by Ciara Freeman, MD, PhD

If you’d like to learn more about our approach to blood and bone marrow transplant procedures, you can request an appointment by 1-888-663-3488 or completing a new patient registration form online. You do not need a referral to meet with a blood and bone marrow transplant specialist at Moffitt Cancer Center, where we provide every aspect of treatment and supportive care in a single, convenient location.

  • BMT and CI Leadership
    Frederick  Locke, MD
    Department Chair, Blood and Marrow Transplant and Cellular Immunotherapy
    Program Lead, Blood and Marrow Transplant and Cellular Immunotherapy

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Title

    Program Co-Leader, Immuno-Oncology; Chair, Department of Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Nelli  Bejanyan, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Title

    Program Leader, Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

  • Blood and Marrow Transplant and Cellular Immunotherapy
    Melissa  Alsina, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Leukemia, Multiple Myeloma-Plasma Cell Tumor

    4.9 (204)
    Claudio  Anasetti, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Leukemia, Multiple Myeloma-Plasma Cell Tumor, Myelodysplastic Syndromes (MDS)

    Nelli  Bejanyan, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Title

    Program Leader, Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Leukemia, MDS, Myelodysplastic Syndromes (MDS)

    Kaaron  Benson, MD

    Program

    Pathology

    Specialty

    Pathology

    Cancer Focus

    Hodgkin Lymphoma, Leukemia, MDS, Multiple Myeloma-Plasma Cell Tumor, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma

    Margaret  Booth-Jones, PhD

    Program

    Supportive Care Medicine

    Specialty

    Clinical Psychology

    4.9 (155)
    Omar  Castaneda Puglianini, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Medical Oncology

    Cancer Focus

    Multiple Myeloma-Plasma Cell Tumor

    5 (45)
    Yehuda  Deutsch, MD

    Program

    Malignant Hematology and Cellular Therapy at Memorial Healthcare System

    Specialty

    Hematology/Oncology

    Cancer Focus

    Hodgkin Lymphoma, Leukemia, MDS, Multiple Myeloma-Plasma Cell Tumor, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma

    Hany  Elmariah, MD, MS

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Leukemia, MDS, Myelodysplastic Syndromes (MDS)

    4.9 (51)
    Rawan  Faramand, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Leukemia, MDS, Myelodysplastic Syndromes (MDS)

    4.8 (41)
    Hugo  Fernandez, MD
    Department Chair, Malignant Hematology and Cellular Therapy at Memorial Healthcare System
    Program Lead, Malignant Hematology and Cellular Therapy at Memorial Healthcare System

    Program

    Malignant Hematology and Cellular Therapy at Memorial Healthcare System

    Title

    Chair, Malignant Hematology and Cellular Therapy at Memorial Healthcare System

    Specialty

    Medical Oncology

    Cancer Focus

    Leukemia, Myelodysplastic Syndromes (MDS)

    Ciara  Freeman, MD, PhD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Medical Oncology

    4.9 (35)
    Doris  Hansen, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Hodgkin Lymphoma, Leukemia, Multiple Myeloma-Plasma Cell Tumor, Non-Hodgkin Lymphoma

    5 (18)
    Michael  Jain, MD, PhD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    4.9 (30)
    Farhad  Khimani, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Hodgkin Lymphoma, Leukemia, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma

    4.8 (30)
    Aleksandr  Lazaryan, MD, MPH, PhD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Cutaneous Lymphoma (CTCL), Hodgkin Lymphoma, Non-Hodgkin Lymphoma

    5 (32)
    Hien  Liu, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Cutaneous Lymphoma (CTCL), Hodgkin Lymphoma, Non-Hodgkin Lymphoma

    4.9 (36)
    Frederick  Locke, MD
    Department Chair, Blood and Marrow Transplant and Cellular Immunotherapy
    Program Lead, Blood and Marrow Transplant and Cellular Immunotherapy

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Title

    Program Co-Leader, Immuno-Oncology; Chair, Department of Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Hodgkin Lymphoma, Leukemia, Multiple Myeloma-Plasma Cell Tumor, Non-Hodgkin Lymphoma

    Sayeef  Mirza, MD, MPH

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Hematology/Oncology

    Cancer Focus

    Hodgkin Lymphoma, Leukemia, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma

    Asmita  Mishra, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Leukemia, MDS, Myelodysplastic Syndromes (MDS)

    Michael  Nieder, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Taiga  Nishihori, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Cutaneous Lymphoma (CTCL), Hodgkin Lymphoma, Leukemia, MDS, Multiple Myeloma-Plasma Cell Tumor, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma, Testicular Cancer

    4.9 (40)
    Jose  Ochoa-Bayona, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Leukemia, Multiple Myeloma-Plasma Cell Tumor, Ovarian Cancer, Testicular Cancer

    4.9 (33)
    Lia  Perez, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Hodgkin Lymphoma, Leukemia, MDS, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma

    Fabiana  Perna, MD, PhD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Hematology

    Cancer Focus

    Hodgkin Lymphoma, Leukemia, MDS, Multiple Myeloma-Plasma Cell Tumor, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma

    Joseph  Pidala, MD, PhD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Leukemia, MDS, Myelodysplastic Syndromes (MDS)

    Ramon  Sandin, MD, MS

    Program

    Pathology

    Specialty

    Pathology

    Cancer Focus

    Hodgkin Lymphoma, Leukemia, MDS, Multiple Myeloma-Plasma Cell Tumor, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma

    Jose  Sandoval Sus, MD

    Program

    Malignant Hematology and Cellular Therapy at Memorial Healthcare System

    Specialty

    Hematology/Oncology

    Cancer Focus

    Hodgkin Lymphoma, Leukemia, MDS, Multiple Myeloma-Plasma Cell Tumor, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma

    Karla  Adams, PA-C

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Danielle  Baratta, PA-C

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Chrissy  Copponex, APRN

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Marian  Dam, APRN

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    KC  Garfield, APRN

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    William  Giove, PA

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Kristy  Harvey, PA-C

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Erik  Hollers, PA-C

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Nikita  Hope, APRN

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Meredith  Keppel, PA-C

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Jessica  Marin, PA-C

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Hematology/Oncology

    Cancer Focus

    Leukemia, Multiple Myeloma-Plasma Cell Tumor, Non-Hodgkin Lymphoma

    Catherine  Quealy, APRN

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Hematology/Oncology

    Cancer Focus

    Hodgkin Lymphoma, Leukemia, Multiple Myeloma-Plasma Cell Tumor, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma